The FDA ordered Endo Pharmaceuticals to remove its opioid painkiller Opana ER from the market after concerns over potential abuse, CNN reports.
Here's what you should know:
1. FDA Commissioner Scott Gottlieb, MD, said to CNN that the agency is taking action to remove the medication if its potential risks outweigh its benefits.
2. Opana ER contributed to a HIV outbreak among an Indiana-based addict population in 2015, CNN reports. HIV spread among the addicts who were sharing a needle to inject Opana into their bloodstream.
3. The drug is approximately two times as powerful as OxyContin.
4. The FDA originally approved Opana in 2006.
More articles on quality:
North America leading the way in the infection control market: 5 things to know
Toxic anterior segment syndrome in ASCs: 4 notes
Yelp, Vitals, Healthgrades physician ratings don't match quality scores: 5 key notes
